CRIS Current Research Information System

CARACENI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.483
EU - Europa 8.764
AS - Asia 3.138
AF - Africa 500
SA - Sud America 37
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.942
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.459
IT - Italia 2.238
GB - Regno Unito 2.018
VN - Vietnam 1.234
SE - Svezia 1.168
DE - Germania 972
CN - Cina 953
IN - India 448
UA - Ucraina 408
FR - Francia 350
IE - Irlanda 342
RU - Federazione Russa 283
CH - Svizzera 273
SG - Singapore 234
BG - Bulgaria 229
TG - Togo 221
ZA - Sudafrica 157
EE - Estonia 156
JO - Giordania 108
CI - Costa d'Avorio 70
ES - Italia 60
IR - Iran 58
FI - Finlandia 55
BE - Belgio 42
NL - Olanda 41
JP - Giappone 30
GR - Grecia 25
HR - Croazia 25
CA - Canada 23
SC - Seychelles 23
NG - Nigeria 20
HK - Hong Kong 18
AT - Austria 15
CZ - Repubblica Ceca 12
BR - Brasile 11
CL - Cile 11
LB - Libano 10
AU - Australia 9
PT - Portogallo 9
RO - Romania 9
PL - Polonia 8
TR - Turchia 8
UZ - Uzbekistan 8
EC - Ecuador 7
EU - Europa 6
AL - Albania 5
EG - Egitto 5
PH - Filippine 5
IL - Israele 4
NZ - Nuova Zelanda 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
DK - Danimarca 3
MK - Macedonia 3
MY - Malesia 3
RS - Serbia 3
TW - Taiwan 3
BD - Bangladesh 2
ID - Indonesia 2
KR - Corea 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NO - Norvegia 2
SI - Slovenia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BY - Bielorussia 1
HU - Ungheria 1
KE - Kenya 1
LK - Sri Lanka 1
MN - Mongolia 1
PK - Pakistan 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
Totale 22.942
Salva come PNG Salva come JPEG
Città #
Southend 1.824
Fairfield 1.433
Chandler 1.137
Ashburn 820
Dong Ket 773
Woodbridge 717
Wilmington 640
Seattle 608
Houston 591
Cambridge 547
Princeton 493
Bologna 371
Ann Arbor 352
Dublin 341
Bern 247
Jacksonville 226
Sofia 226
Lomé 221
Westminster 187
Nanjing 185
Singapore 181
Padova 174
Milan 144
Berlin 143
Amman 108
Shenyang 106
Saint Petersburg 97
San Diego 91
Jinan 89
Boardman 83
Rome 81
New York 80
Florence 79
Redmond 77
Turin 76
Beijing 71
Abidjan 70
Medford 64
Changsha 62
Nanchang 57
Mülheim 55
Hebei 54
Dearborn 52
Bremen 47
Helsinki 45
Redwood City 41
Brussels 39
Jiaxing 39
Tianjin 36
Falls Church 33
Los Angeles 33
Des Moines 31
Norwalk 30
Olalla 30
Ningbo 28
Ardabil 27
Grafing 27
Paris 27
Zhengzhou 25
Barcelona 23
Mahé 22
Guangzhou 21
Tokyo 21
Chicago 20
Haikou 20
Mountain View 20
Abeokuta 19
Fremont 19
Hangzhou 19
Modena 17
Hong Kong 16
Lanzhou 16
Washington 16
Boydton 15
Kunming 15
London 15
Zanjan 15
Amsterdam 14
Fuzhou 14
Taizhou 14
Toronto 14
Leawood 13
Palermo 13
Verona 13
Bari 12
Bühl 12
Cesena 12
Dallas 12
Naples 12
Hefei 11
Kuban 11
Napoli 11
Taiyuan 11
Faenza 10
Ferrara 10
Lappeenranta 10
Lausanne 10
Leganés 10
Pune 10
San Jose 10
Totale 15.169
Salva come PNG Salva come JPEG
Nome #
L’arterializzazione della vena porta per insuffcienza epatica acuta 476
Arterializzazione della vena porta per il trattamento dell’insufficenza epatica acuta secondaria ad estesa resezione epatica nel ratto. 398
Le alterazioni dell’emodinamica sistemica e distrettuale come fattori patogenetici nella cirrosi scompensata. 233
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 207
A novel model of CCl4-induced cirrosi with ascites in the mouse. 175
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 174
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 173
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 172
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 171
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 171
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 167
null 164
L’albumina nelle malattie del fegato. 161
Acute Liver Failure Caused by Amanita phalloides Poisoning 161
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 157
569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE? 156
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 152
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 147
A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure 146
A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge 146
Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma 142
null 142
Dossier Epatologia: Sindrome epatopolmonare e ipertensione portopolmonare. 141
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 140
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 140
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 138
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 138
null 138
Portal vein arterialization in a patient with acute liver failure 137
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 136
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 134
First report of fulminant hepatic failure treated with portal v ein arterialization avoiding liver transplantation 134
Cardiac electrophysiological abnormalities in patients with cirrhosis. 132
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 131
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 131
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 130
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 129
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 128
Insufficienza epatica acuta ed epatite subacuta. 128
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 128
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 127
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 127
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 127
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 127
Clinical indications for the albumin use: Still a controversial issue. 126
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 126
Soluble Receptor Activator of Nuclear Factor-kB Ligand (sRANKL)/Osteoprotegerin balance in ageing and age-associated diseases. 125
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain 125
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 124
A case of prolonged cholestatic hepatitis induced by azithromycin in a young woman 124
Monofocal hepatocellular carcinoma: How much does size matter? 124
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 123
CCL4-induced acute liver failure with portal vein arterialization in the rat 123
Linee-guida per l’uso clinico dell’albumina: l’esperienza del Policlinico S. Orsola-Mallpighi di Bologna. 123
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 122
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 122
Hyperoxia fully protects mitochondria of explanted livers 121
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 121
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 120
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 120
Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. 119
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 119
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 119
The analysis of food intake in patients with cirrhosis waiting for liver transplantation: A neglected step in the nutritional assessment 119
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 118
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 118
CCL4-Induced acute liver failure with portal vein arterialization in the rat 117
Metabolic disorders across hepatocellular carcinoma in Italy 117
null 117
null 115
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival. 115
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 114
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 113
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 112
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 112
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 112
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 112
Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. 111
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 110
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 110
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 109
First report of fulminant hepatic failure treated with portal vein arterialization avoiding liver transplantation 108
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 108
Portal vein arterialization: a new surgical option against acute liver failure? 108
The endocannabinoid system and liver diseases. 107
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 107
null 107
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 106
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 106
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 105
Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications. 105
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis. 104
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 104
Complicanze della cirrosi epatica: le infezioni batteriche. 103
Development and validation of a prognostic score to predict mortality in patients with acute on chronic liver failure. 103
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 102
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 102
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 102
Years of life that could be saved from prevention of hepatocellular carcinoma. 101
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 101
Totale 13.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.657 0 137 62 316 536 551 691 710 756 363 215 320
2020/20213.838 595 234 106 206 88 171 114 224 356 205 166 1.373
2021/20224.776 410 158 317 369 405 248 155 391 186 274 1.163 700
2022/20235.219 505 753 284 601 321 429 177 294 864 167 402 422
2023/20241.931 122 265 119 190 122 386 112 145 72 143 158 97
2024/2025325 295 30 0 0 0 0 0 0 0 0 0 0
Totale 23.641